925 Results

People

  1. Brennan
    Brennan
  2. Eastham
    Eastham
  3. Fong
    Fong
  4. Kris
    Kris
  5. Abrey
    Abrey
  6. Antonescu
    Antonescu
  7. DeMatteo
    DeMatteo
  8. Busam
    Busam
  9. Scardino
    Scardino
  10. De Angelis
    De Angelis

Groups

  1. Department of Medicine (382)
  2. Surgery (248)
  3. Solid Tumor Oncology Division (200)
  4. Survivorship Research (133)
  5. GSK Faculty (131)
  6. Department of Pathology and Laboratory Medicine (126)
  7. Center for Hematologic Malignancies (120)
  8. Sloan Kettering Institute Faculty (119)
  9. Hematologic Malignancies, Division of (118)
  10. Division of Subspecialty Medicine (100)
  1. "disease course"
Formats
  1. Journal Article (891)
  2. Review (13)
  3. Editorial (7)
  4. Research Letter (5)
  5. Correspondence (3)
  6. Guidelines (3)
  7. Conference Paper (2)
  8. Book Section (1)
Groups
  1. Department of Medicine (382)
  2. Surgery (248)
  3. Solid Tumor Oncology Division (200)
  4. Survivorship Research (133)
  5. GSK Faculty (131)
  6. Department of Pathology and Laboratory Medicine (126)

More Groups

People
  1. Peter Scardino (25)
  2. Murray Brennan (24)
  3. James Eastham (22)
  4. Mark Kris (22)
  5. Yuman Fong (22)
  6. David Klimstra (21)

More People

Years
  1. 2025 (5)
  2. 2024 (25)
  3. 2023 (16)
  4. 2022 (13)
  5. 2021 (7)
  6. 2020 (24)

More Years

Publications
  1. Journal of Clinical Oncology (52)
  2. Cancer (42)
  3. Gynecologic Oncology (22)
  4. American Journal of Surgical Pathology (20)
  5. Clinical Cancer Research (20)
  6. Journal of the National Comprehensive Cancer Network (18)

More Publications

Publishers
  1. Elsevier Inc. (133)
  2. Wiley Blackwell (75)
  3. Lippincott Williams & Wilkins (64)
  4. Springer (63)
  5. Elsevier Science, Inc. (60)
  6. American Society of Clinical Oncology (55)

More Publishers

Results (925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Guidelines

    Oaknin, A.; Bosse, T. J.; Creutzberg, C. L.; Giornelli, G.; Harter, P.; Joly, F.; Lorusso, D.; Marth, C.; Makker, V.; Mirza, M. R.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma
    Research Letter

    Jaeger, U.; Tam, C. S.; Borchmann, P.; McGuirk, J. P.; Johansen, M.; Waller, E. K.; Jaglowski, S.; Andreadis, C.; Foley, S. R.; Westin, J. R.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • A word of caution on using tumor biomarker reference change values to guide medical decisions and the need for alternatives
    Correspondence

    van Rossum, H. H.; Meng, Q. H.; Ramanathan, L. V.; Holdenrieder, S.
    Clinical Chemistry and Laboratory Medicine (2022)

    Fulltext@MSK | Save
  • Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: Final results from the BFORE trial
    Journal Article

    Brümmendorf, T. H.; Cortes, J. E.; Milojkovic, D.; Gambacorti-Passerini, C.; Clark, R. E.; le Coutre, P.; Garcia-Gutierrez, V.; Chuah, C.; Kota, V.; Lipton, J. H.; more...
    Leukemia (2022)

    Fulltext@MSK | Save
  • Coping with glioblastoma: Prognostic communication and prognostic understanding among patients with recurrent glioblastoma, caregivers, and oncologists
    Journal Article

    Walsh, L. E.; Polacek, L. C.; Panageas, K.; Reiner, A.; Walbert, T.; Thomas, A. A.; Buthorn, J.; Sigler, A.; Prigerson, H. G.; Applebaum, A. J.; more...
    Journal of Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Highly favorable outcomes with salvage radiation therapy and autologous hematopoietic cell transplantation in relapsed and refractory DLBCL patients with minimal to no response to salvage chemotherapy
    Research Letter

    Yang, J. C.; Scordo, M.; Chau, K. W.; Sauter, C. S.; Yahalom, J.
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: A multicentre, open-label, phase 2 study
    Journal Article

    Zauderer, M. G.; Szlosarek, P. W.; Le Moulec, S.; Popat, S.; Taylor, P.; Planchard, D.; Scherpereel, A.; Koczywas, M.; Forster, M.; Cameron, R. B.; more...
    Lancet Oncology (2022)

    Fulltext@MSK | Save
  • Bilateral regional nodal irradiation using volumetric modulated arc therapy: Dosimetric analysis and feasibility
    Journal Article

    Bernstein, M. B.; Walker, K.; Gillespie, E.; Mueller, B.; Cuaron, J.; Xu, A.; McCormick, B.; Khan, A.; Cahlon, O.; Powell, S.; more...
    Practical Radiation Oncology (2022)

    Fulltext@MSK | Save
  • Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm–blast phase
    Journal Article

    Wang, X.; Rampal, R. K.; Hu, C. S.; Tripodi, J.; Farnoud, N.; Petersen, B.; Rossi, M. R.; Patel, M.; McGovern, E.; Najfeld, V.; more...
    JCI Insight (2022)

    Fulltext@MSK | Save
  • Disease course and outcomes of COVID-19 among hospitalized patients with gastrointestinal manifestations
    Journal Article

    Laszkowska, M.; Faye, A. S.; Kim, J.; Truong, H.; Silver, E. R.; Ingram, M.; May, B.; Ascherman, B.; Bartram, L.; Zucker, J.; more...
    Clinical Gastroenterology and Hepatology (2021)

    Fulltext@MSK | Save